Abbott Laboratories
NYSE:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbott Laboratories
NYSE:ABT
|
US |
|
Ingersoll Rand Inc
NYSE:IR
|
US |
|
Entegris Inc
NASDAQ:ENTG
|
US |
|
Vaxart Inc
NASDAQ:VXRT
|
US |
|
S
|
Seven West Media Ltd
XBER:WA7
|
AU |
|
Ensign Group Inc
NASDAQ:ENSG
|
US |
|
Blackline Safety Corp
TSX:BLN
|
CA |
|
Woodside Energy Group Ltd
NYSE:WDS
|
AU |
|
Mahanagar Gas Ltd
NSE:MGL
|
IN |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 120.77 USD with a low forecast of 92.92 USD and a high forecast of 142.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
120.77
USD
According to Wall Street analysts, the average 1-year price target for ABT is 120.77 USD with a low forecast of 92.92 USD and a high forecast of 142.8 USD.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
